首页|分化型甲状腺癌131I治疗后颈部转移淋巴结与刺激状态下甲状腺球蛋白之间关系

分化型甲状腺癌131I治疗后颈部转移淋巴结与刺激状态下甲状腺球蛋白之间关系

扫码查看
目的 探讨分化型甲状腺癌(differentiated thyroid cancer,DTC)术后131I治疗后局部淋巴结转移与刺激状态下甲状腺球蛋白(stimulated thyroglobulin,sTg)之间关系。方法 回顾性分析2016年9月至2020年9月于郑州大学第一附属医院核医学科行131I 100~150 mCi治疗157例的分化型甲状腺癌患者临床资料,所有患者131I治疗4~5月后停服左甲状腺素钠片3~4周均确诊颈部淋巴结转移病灶。统计患者颈部转移淋巴结个数及直径、颈部淋巴结分区、sTg、性别等临床资料。对sTg值与颈部转移淋巴结病灶个数及直径之间行Spearman相关分析;对于颈部淋巴结复发不同区域之间、sTg阳性与sTg阴性组间患者性别、患者病灶复发部位(颈部单侧或双侧)间差异行x2检验;对sTg阳性与sTg阴性组间患者所检出病灶个数行t检验。结果 在刺激状态下,157例颈部淋巴结转移患者中,Ⅲ区与Ⅳ区是常见转移部位(P<0。05),颈部单侧转移较双侧转移多见(P<0。05)。sTg与颈部转移淋巴结个数及直径之间成线性关系(分别为r=0。517、P<0。05;r=0。361、P<0。05);sTg阳性与sTg阴性患者中性别、病灶数目、病灶复发部位之间差别有统计学意义(P<0。05)。结论 sTg可作为DTC术后131I治疗后肿瘤标志物,能反映DTC患者131I治疗后颈部复发淋巴结个数与大小;且sTg阳性与sTg阴性患者之间性别、病灶数目及病灶部位之间有差别;但sTg阴性,不能排除体内无转移病灶。
Relationship between sTg and cervical lymph node metastasis in patients with DTC after thyroidectomy and 131I treatment
Objective To explore the relationship between local lymph node metastasis and stimulated thyroglobulin(sTg)after 131I treatment for differentiated thyroid cancer(DTC).Methods A retrospective analysis of the clinical da-ta of 157 patients with differentiated thyroid cancer who underwent 131I 100-150mCi treatment in the Department of Nu-clear Medicine of the First Affiliated Hospital of Zhengzhou University from September 2016 to September 2020.Patients who were treated with 131I for 4 to 5 months later stopped taking levothyroxine sodium tablets for 3 to 4 weeks and were diagnosed with cervical lymph node metastasis.Spearman correlation analysis was performed on the sTg value and the number and diameter of cervical metastatic lymph node lesions;x2 test was performed for the difference between different regions of recurrent cervical lymph nodes,gender between sTg-positive and sTg-negative groups,and the difference between the recurrence sites of patients(one or both sides of the neck);t test was performed on the number of lesions detected between the sTg-positive and sTg-negative groups.Results In the stimulated state,among the 157 patients with cervical lymph node metastasis,area Ⅲ and Ⅳ were the common metastatic sites(P<0.05),and unilateral me-tastases were more common than bilateral metastases(P<0.05).There is a linear relationship between sTg and the number and diameter of cervical metastatic lymph nodes(r=0.517,P<0.05;r=0.361,P<0.05);there was a statistically significant difference between the patient's gender,number of lesions,and location of lesions in patients with sTg positive and sTg negative(P<0.05).Conclusion sTg can be used as a tumor marker for patients with DTC after thyroidectomy and 131I treatment,and there are differences be-tween sTg-positive and-negative in gender,number of lesions,and location of lesions.But sTg negative cannot rule out no metastatic disease in the body.

Differentiated thyroid carcinomaThyroglobulinThyroglobulin antibody131ICervical lymph node

李祥周、李彦鹏、温鑫、闫志华、程兵

展开 >

郑州大学第一附属医院核医学科,郑州 450003

分化型甲状腺癌 甲状腺球蛋白 甲状腺球蛋白抗体 131I 颈部淋巴结

河南省重点研发与推广专项(科技攻关)项目

212102310176

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(12)